These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 36109762)
21. Cancer-associated fibroblasts barrier breaking via TGF-β blockade paved way for docetaxel micelles delivery to treat pancreatic cancer. Pang N; Yang Z; Zhang W; Du Y; Zhang L; Li X; Peng Y; Qi X Int J Pharm; 2024 Nov; 665():124706. PubMed ID: 39277152 [TBL] [Abstract][Full Text] [Related]
22. Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer. Doddapaneni R; Patel K; Chowdhury N; Singh M Sci Rep; 2017 Nov; 7(1):15824. PubMed ID: 29158480 [TBL] [Abstract][Full Text] [Related]
23. Effect of the structure of ginsenosides on the Chen C; Xia J; Ren H; Wang A; Zhu Y; Zhang R; Gan Z; Wang J Asian J Pharm Sci; 2022 Mar; 17(2):219-229. PubMed ID: 35582640 [TBL] [Abstract][Full Text] [Related]
25. Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer. He C; Cai P; Li J; Zhang T; Lin L; Abbasi AZ; Henderson JT; Rauth AM; Wu XY J Control Release; 2017 Jan; 246():98-109. PubMed ID: 28017889 [TBL] [Abstract][Full Text] [Related]
26. Polysaccharides from Lentinus edodes prevent acquired drug resistance to docetaxel in prostate cancer cells by decreasing the TGF-β1 secretion of cancer-associated fibroblasts. Zhang W; Tao N; Bai L J Nat Med; 2023 Sep; 77(4):817-828. PubMed ID: 37354258 [TBL] [Abstract][Full Text] [Related]
27. Programmed Co-delivery of tamoxifen and docetaxel using lipid-coated mesoporous silica nanoparticles for overcoming CYP3A4-mediated resistance in triple-negative breast cancer treatment. Wang Y; Cheng W; Zhu J; He L; Ren W; Bao D; Piao JG Biomed Pharmacother; 2024 Jan; 170():116084. PubMed ID: 38157645 [TBL] [Abstract][Full Text] [Related]
28. Rhein potentiates doxorubicin in treating triple negative breast cancer by inhibiting cancer-associated fibroblasts. Xu S; Zheng S; Ma N; Zhang H; Shi J; Huang J; Luo N; Wang M; Xiong Y Biochem Pharmacol; 2024 May; 223():116139. PubMed ID: 38499109 [TBL] [Abstract][Full Text] [Related]
29. Enhanced antitumor effect on intrapulmonary tumors of docetaxel lung-targeted liposomes in a rabbit model of VX2 orthotopic lung cancer. Wang L; Li R; Che K; Liu Z; Xiang S; Li M; Yu Y Sci Rep; 2017 Aug; 7(1):10069. PubMed ID: 28855665 [TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer. Palma G; Conte C; Barbieri A; Bimonte S; Luciano A; Rea D; Ungaro F; Tirino P; Quaglia F; Arra C Int J Pharm; 2014 Oct; 473(1-2):55-63. PubMed ID: 24992317 [TBL] [Abstract][Full Text] [Related]
31. One Stone Four Birds: A Novel Liposomal Delivery System Multi-functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy. Hong C; Liang J; Xia J; Zhu Y; Guo Y; Wang A; Lu C; Ren H; Chen C; Li S; Wang D; Zhan H; Wang J Nanomicro Lett; 2020 Jun; 12(1):129. PubMed ID: 34138128 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of micellar-like terpolymer nanoparticles with reductively-cleavable cross-links and evaluation of efficacy in 2D and 3D models of triple negative breast cancer. Monteiro PF; Gulfam M; Monteiro CJ; Travanut A; Abelha TF; Pearce AK; Jerôme C; Grabowska AM; Clarke PA; Collins HM; Heery DM; Gershkovich P; Alexander C J Control Release; 2020 Jul; 323():549-564. PubMed ID: 32371266 [TBL] [Abstract][Full Text] [Related]
33. Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer. Liu Y; Qiu N; Shen L; Liu Q; Zhang J; Cheng YY; Lee KH; Huang L J Control Release; 2020 Jul; 323():431-441. PubMed ID: 32360890 [TBL] [Abstract][Full Text] [Related]
34. Influence of type and proportion of lyoprotectants on lyophilized ginsenoside Rg3 liposomes. Li J; Hu M; Xu H; Yu X; Ye F; Wang K; Luan X; Li L; Zhang D J Pharm Pharmacol; 2016 Jan; 68(1):1-13. PubMed ID: 26806695 [TBL] [Abstract][Full Text] [Related]
35. Sequential Delivery of Quercetin and Paclitaxel for the Fibrotic Tumor Microenvironment Remodeling and Chemotherapy Potentiation via a Dual-Targeting Hybrid Micelle-in-Liposome System. Duan H; Liu C; Hou Y; Liu Y; Zhang Z; Zhao H; Xin X; Liu W; Zhang X; Chen L; Jin M; Gao Z; Huang W ACS Appl Mater Interfaces; 2022 Mar; 14(8):10102-10116. PubMed ID: 35175043 [TBL] [Abstract][Full Text] [Related]
36. Dual-targeting liposomes with active recognition of GLUT Pu Y; Zhang H; Peng Y; Fu Q; Yue Q; Zhao Y; Guo L; Wu Y Eur J Med Chem; 2019 Dec; 183():111720. PubMed ID: 31553933 [TBL] [Abstract][Full Text] [Related]
37. Acetic acid transporter-mediated, oral, multifunctional polymer liposomes for oral delivery of docetaxel. Guo X; Zhang J; Cai Q; Fan S; Xu Q; Zang J; Yang H; Yu W; Li Z; Zhang Z Colloids Surf B Biointerfaces; 2021 Feb; 198():111499. PubMed ID: 33317899 [TBL] [Abstract][Full Text] [Related]
38. Nano-baicalein facilitates chemotherapy in breast cancer by targeting tumor microenvironment. Zheng F; Luo Y; Liu Y; Gao Y; Chen W; Wei K Int J Pharm; 2023 Mar; 635():122778. PubMed ID: 36842519 [TBL] [Abstract][Full Text] [Related]
39. Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody. Wu H; Wei G; Luo L; Li L; Gao Y; Tan X; Wang S; Chang H; Liu Y; Wei Y; Song J; Zhang Z; Huo J Biomater Res; 2022 Dec; 26(1):77. PubMed ID: 36494759 [TBL] [Abstract][Full Text] [Related]
40. How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition-A formulation screening study. Holsæter AM; Wizgird K; Karlsen I; Hemmingsen JF; Brandl M; Škalko-Basnet N Eur J Pharm Sci; 2022 Oct; 177():106267. PubMed ID: 35872073 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]